about
Prolactin receptor signaling is essential for perinatal brown adipocyte function: a role for insulin-like growth factor-2Drawing up guidelines for the attendance of physical health of patients with severe mental illnessHypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytesAtypical beta-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptorTumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is highly induced by tumor necrosis factor-alpha and adipose conversionThe extreme C terminus of rat liver carnitine palmitoyltransferase I is not involved in malonyl-CoA sensitivity but in initial protein foldingPioglitazone could induce remission in major depression: a meta-analysisTranscriptional down-regulation by insulin of the beta 3-adrenergic receptor expression in 3T3-F442A adipocytes: a mechanism for repressing the cAMP signaling pathway.The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation.The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age.Adipogenesis: cellular and molecular aspects.Recent advances in the relationship between obesity, inflammation, and insulin resistance.Adipokines: the missing link between insulin resistance and obesity.The role of interleukins in insulin resistance and type 2 diabetes mellitus.Semicarbazide-sensitive amine oxidase in annulo-aortic ectasia disease: relation to elastic lamellae-associated proteins.Diabetes and inflammation: fundamental aspects and clinical implications.Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.Long term phorbol ester treatment down-regulates the beta 3-adrenergic receptor in 3T3-F442A adipocytes.Transcriptional modulation by n-butyric acid of beta 1-, beta 2-, and beta 3-adrenergic receptor balance in 3T3-F442A adipocytes.In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes.New adipokines.Oleuropein activated AMPK and induced insulin sensitivity in C2C12 muscle cells.Severe insomnia is associated with hypertriglyceridemia in women with major depression treated in psychiatry settings.PPAR-γ Agonists for the Treatment of Major Depression: A Review.Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.Evaluation of hypocholesterolemic effect of oleuropein in cholesterol-fed rats.No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.Triiodothyronine regulates beta 3-adrenoceptor expression in 3T3-F442A differentiating adipocytes.Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human.NOV/CCN3: A New Adipocytokine Involved in Obesity-Associated Insulin Resistance.A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats.Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome.Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort.Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis.Thyroid-stimulating hormone, 5-HTTLPR genotype, and antidepressant response in depressed women.Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging.Antenatal antipsychotic exposure induces multigenerational and gender-specific programming of adiposity and glucose tolerance in adult mouse offspring.The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients.
P50
Q27302085-2427000D-AB1C-44E5-9881-C9547C5F27F2Q28258290-78F58EB5-A9C3-4AD0-BA83-4ADC29559C97Q28261080-38F77740-F8A1-4D85-A756-8E3499E88999Q28323048-1ECF8BF3-C927-42AF-A028-11ADD2DCE0FFQ28511255-3347FE72-3ECD-4DF1-94BF-24B50F83DC2CQ28577659-3255152D-9E65-4F54-BB45-C2B5147A331CQ34548227-5EC8331B-9C05-4A64-A333-EDEDE1D30758Q35519745-9209441E-949A-4CCD-9F98-3086133498F7Q35935135-958C5017-1C68-4E91-95BB-9C6313375FB8Q36302559-C47404D0-8C5F-4FA9-A2FA-F3C57C9A3474Q36324040-C84088BC-EFD2-4407-8DF8-5E0B14BCBEB6Q36448850-7D9968E2-C44A-4D01-8AA7-4997BB90FA92Q37038003-FBE7C8E5-0297-4CC3-8F89-AEB1532248FBQ37462159-77C9B038-6D40-4C04-9EDE-DBA870CE907BQ37643574-9002EBA0-5DE7-4C08-9169-96B95B51932FQ37790134-8C4878A6-2395-410E-A3C2-7D49C969F868Q38247488-395CD8AD-567D-4A90-85ED-6E7197CB8F04Q38295535-964CCE78-E051-4473-8018-009BEEE487F2Q38310331-47264DBA-EE14-49EB-85C0-38C8335357CAQ38346020-C33485AA-B522-4C5A-BDBC-358BE45F00FBQ38725188-8934CB5D-CF92-4E9D-A7F3-3CAAFD4A6B55Q38794501-31946EDF-E750-4184-B98F-7ED0A302D082Q38835981-AB9D7AA4-9030-434A-9C23-7D39C46AD59CQ39039308-69439A42-8EB8-42D7-A50F-4DA0DED8464DQ39298349-B90D0309-88F0-475B-B373-F1F0690B39CAQ39885463-624D3F99-7855-4703-801D-92E82E0EB2DDQ40314455-FDC74F9D-DC0B-4326-BFF5-4B97D2706200Q41184644-D6CB8867-8D64-41E2-97CC-00D499574664Q41469551-A4C1BCCB-4D5F-43A9-BE21-F0E157B6A48CQ42488706-423109A3-C5FA-498B-8DC5-350057C632C0Q42809862-1663B4C6-B720-4CE4-A1AF-FAB9DB570ED7Q42817194-CD8D7877-22B7-4461-80F4-EA5A18D7FE52Q42818112-10776799-195C-4810-9733-71E48F49195EQ42829877-8D771520-BD65-42A8-910F-2F97CDD861CBQ43233636-2A956CD7-643D-43B9-BF94-7A338633A681Q46727038-CE20480B-0AC5-468C-835A-4B2A122257CBQ46888635-64DBCDE6-76CA-4D76-81EA-34F5CCA929FEQ47169231-DCD77A8A-DA42-4B62-84F9-51C525735F2EQ47691255-6DCE69F2-CDE2-487A-8E5A-22E34C585437Q47739510-460C86A9-59E8-4C45-A361-93794C342074
P50
description
researcher ORCID ID = 0000-0001-6577-9009
@en
wetenschapper
@nl
name
Bruno Feve
@ast
Bruno Feve
@en
Bruno Feve
@es
Bruno Feve
@nl
type
label
Bruno Feve
@ast
Bruno Feve
@en
Bruno Feve
@es
Bruno Feve
@nl
prefLabel
Bruno Feve
@ast
Bruno Feve
@en
Bruno Feve
@es
Bruno Feve
@nl
P21
P31
P496
0000-0001-6577-9009